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Sex chromosomes: Evolving dosage compensation
Brian Charlesworth
Dosage compensation of some X-linked genes varies
among mammals. Inactivation of an X-linked copy of a
gene in females appears to correlate with lack of an
active homologue on the Y chromosome, implying that
dosage compensation evolves in response to the loss
of function of genes on the Y.
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The Y chromosome is a genetic and evolutionary enigma.
In groups like mammals and Drosophila with advanced
systems of chromosomal sex determination, the Y lacks
most of the thousands of genes carried on its pairing
partner at meiosis, the X chromosome. Comparative
studies suggest strongly that the X and Y chromosomes
were originally largely homologous, probably differing by
only a few genes concerned with sex determination [1–3].
Degeneration of most of the genes on the Y chromosome
has happened repeatedly, in dozens of independent lin-
eages. It is commonly believed that evolution makes
things better not worse: why, then, should such a substan-
tial fraction of the genome have degenerated in this way?
The genetic erosion of the Y chromosome must have been
an evolutionary response to the observed suppression of
recombination between most of the X and Y, which allows
them to evolve independently. As the X can recombine
freely in the homogametic sex, whereas the Y is transmit-
ted as a permanently heterozygous, largely or completely
non-recombining unit, there is an asymmetry in the evolu-
tionary forces operating on them. The smaller number of
copies of the Y in the population as a whole renders it more
vulnerable to the effects of genetic drift. Its lack of genetic
recombination means that natural selection is less effective
in preventing the accumulation of deleterious mutations or
promoting the spread of advantageous ones [2,3].
In several groups with ‘degenerate’ Y chromosomes —
Drosophila, Sciarids, Orthoptera, mammals and nematodes
— the halving of gene dosage for most X-linked loci in the
heterogametic sex is known to be compensated for by
different levels of expression of these genes in the two
sexes, such that the net amount of X-linked gene product
is the same in the two sexes. The evolution of dosage com-
pensation is probably a response to the loss of gene activity
on the Y: if the level of functioning of a Y-linked gene is
low relative to that of its X-linked partner, it will be selec-
tively advantageous for the heterogametic sex to increase
the relative level of activity of the X-linked copy [1–4].
Recent studies of the molecular genetics of mammalian
sex chromosomes are starting to shed light on the details
of the way in which Y chromosomes have evolved, and the
relation between their degeneration and dosage compen-
sation. The basic organization of the human Y chromo-
some is now well understood, and most of the functioning
genes on this chromosome have probably been identified
(Figure 1) [5,6]. A recent screen of testis cDNA with
human Y chromosomal DNA recovered 12 new genes, all
which proved to be located on the non-recombining
portion of the Y. Five of these are single copy genes, each
with an X-linked homologue that codes for a similar
protein sequence, and which are apparently expressed in a
wide range of tissues [6]. The other genes on the Y appear
to lack homologues on the X, and are testis-specific in
their expression (Figure 1).
While it is easy to imagine reasons why genes with male-
specific effects might be sequestered on the Y [2,3,6], the
existence of shared genes on the non-recombining
portion of the Y is not so easily understood. Why should
there be functional genes in common between the X and
Y, outside the pseudoautosomal regions where recombi-
national exchange ensures that the two chromosomes
share genetic information? The most likely interpretation
is that these are genes whose Y-linked copies have simply
not degenerated 
There are several possible explanations for such lack of
degeneration, which are not mutually exclusive. It could
be because degeneration is the product of stochastic
processes with inherent rate variability, because the
fitness effects of loss of the function of the Y-linked copies
are too large to be tolerated, or because they are relatively
recent arrivals on the sex chromosomes and have not had
time to degenerate. The last possibility is supported by
evidence for several additions of autosomal material to
mammalian sex chromosomes over evolutionary time [7].
In any of the three cases, there should be no evidence for
dosage compensation of the genes, as dosage compensa-
tion of a locus is thought to be an evolved response to the
degeneration of its Y-linked homologue. As expected, all
X-linked genes with Y-linked homologues seem not to be
dosage compensated in humans [6].
The question of the relation between dosage compensa-
tion and the retention of homology between X-linked and
Y-linked copies of the same locus has been pursued more
recently in a broader phylogenetic perspective [8]. As is
well known, dosage compensation in mammals involves
the inactivation of one of the two X chromosomes in
somatic cells of females, such that nearly all genes on one
randomly selected chromosome are not transcribed.
Jegalian and Page [8] studied the X-inactivation of four X-
linked genes — ALD, ZFX, RPS4X and SMCX — by assay-
ing the extent of methylation of sequences within these
genes known as ‘CpG islands’, in adult tissues from a
range of mammalian species. Previous studies have
demonstrated a close relation between methylation of an
X-linked allele and its inactivation, so that a detectable
level of methylation of an X-linked gene in females but
not males is indicative of X-inactivation. 
ALD showed the simplest pattern: it was X-inactivated in
all 18 species investigated (selected from nine orders of
eutherian mammals). In the case of ZFX, there was
evidence for methylation only in myomorph rodents
(mouse, rat, hamster and lemming); no methylation was
found in species from ten other orders of eutherian
mammals. This suggests that ZFX was not originally
subject to X-inactivation, and has only become inactivated
in rodents. In contrast, RPS4X is inactivated in all eight
non-primate species tested, but is not inactivated in any of
the eight primate species tested. Finally, SCMCX is inacti-
vated in five out of eleven eutherian orders, not including
primates and myomorphs.
ALD, which lacks a Y-linked copy, presumably
experienced erosion of this copy before the radiation of
eutherians. ZFX has a strongly conserved homologue,
ZFY, in all groups except myomorph rodents, whose ZFY
sequences seem to have diverged considerably from that
of ZFX. This suggests that ZFX was not X-inactivated in
ancestral eutherians, and that functionality of the Y-chro-
mosomal copy has been retained in all groups studied
other than myomorph rodents, where it has either lost
function or diverged in function from ZFX, thereby pro-
moting the evolution of dosage compensation of its homo-
logue. RPS4X, in contrast, seems to have retained a
Y-linked homologue only in primates, consistent with its
pattern of X-inactivation. SCMX shows a more complex
pattern. As predicted, there is no Y-linked homologue in
cattle and guinea pigs, which both show dosage compensa-
tion. In rabbits and goats, however, a male-specific homo-
logue is detectable by Southern blotting, despite the fact
that SCMX shows X-inactivation. But screening of rabbit
cDNA libraries shows no evidence for SCMY clones, sug-
gesting that the gene is not expressed at a high level.
Overall, therefore, there is a good correlation between
dosage compensation of an X-linked gene in a mammalian
species and absence of an active Y-linked homologue,
although some details remain to be clarified. This is 
consistent with models for the evolution of dosage com-
pensation on a gene-by-gene basis [2,3,9], rather than by a
mechanism involving coordinated changes in activity over
large chromosomal regions. Consistent with this, there are
numerous human X-linked genes that do not undergo X
inactivation, but which lack Y-linked homologues [10].
This also indicates that dosage compensation is not an
inevitable concomitant of loss of Y-gene function.
But to explain the inactivation in females of an X-linked
gene whose Y-linked homologue has degenerated in
males, one further postulate must be added: the evolu-
tion of increased activity of the X-linked copy must have
occurred in both females and males. If this happens,
there is then a selective advantage to reduced X-chromo-
somal gene activity in females, thereby restoring the
normal level of gene product. This seems logically
inescapable [2,8], but there is only one observation sup-
porting such a scenario. The Clc4 gene in the mouse Mus
spretus is X-linked, whereas it is autosomal in the close
relative M. musculus. Analysis of mRNA production in
backcross individuals from species hybrids indicates that
the X-linked copy of Clc4 is twice as active as the autoso-
mal copy in both males and females, suggesting that the
copy that has apparently been moved to the X has
acquired enhanced gene activity [11]. It is not known
whether this is an automatic consequence of removal to
the X chromosome, which would suggest a general upreg-
ulation of X-linked genes. Transgenic introductions of
autosomal genes onto the X might illuminate this point.
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Figure 1
The organisation of the human Y chromosome. Positions of cloned
functional genes in the non-recombining portion of the Y are identified
by the vertical lines. Genes with homologues on the X chromosome
are indicated above the diagram of the Y chromosome, and genes
specific to the Y are below. Many of the latter constitute repetitive
gene families. Asterisks indicate newly-isolated Y-linked genes [6].
The centromere is indicated by the filled circle; the extensive region of
Y-chromosomal heterochromatin is indicated by the jagged line; the
two pseudoautosomal regions (which recombine with the X) are
indicated by Ps.
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